Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Financial Calendar

Publication of Annual Report 2007: March 27, 2008

Press and Analyst conference: Zurich, March 27, 2008

Annual Shareholders' meeting:  Zurich, April 24, 2008

Half year report 2008: September 19, 2008